Yale School of Medicine: Beyond Ozempic - Trials Hold Promise of Highly Effective Obesity Drugs
July 01, 2023
July 01, 2023
NEW HAVEN, Connecticut, July 1 (TNSjou) -- Yale School of Medicine issued the following news:
Semaglutide, also known by its brand names Ozempic and Wegovy, marks a new era in anti-obesity therapeutics. The unprecedented drug offers a safe and effective option for patients that addresses the root of obesity. But this is only the beginning. More novel medications are coming down the pipeline that will further revolutionize obesity medicine, with much of the cutting-edge work being le . . .
Semaglutide, also known by its brand names Ozempic and Wegovy, marks a new era in anti-obesity therapeutics. The unprecedented drug offers a safe and effective option for patients that addresses the root of obesity. But this is only the beginning. More novel medications are coming down the pipeline that will further revolutionize obesity medicine, with much of the cutting-edge work being le . . .